ArticleMolecules (Basel, Switzerland)2022
Synthesis and Kinase Inhibitory Potencies of Pyrazolo[3,4-
Mathilde Defois, Chloé Rémondin, Béatrice Josselin, Lionel Nauton, Vincent Théry, Fabrice Anizon, Sandrine Ruchaud, Francis Giraud, Pascale Moreau
Open access · goldAbstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 1 institution in 1 country.
Mathilde DefoisUniversité Clermont Auvergne, CNRS, Clermont Auvergne INP, ICCF, F-63000 Clermont-Ferrand, France.
Chloé RémondinUniversité Clermont Auvergne, CNRS, Clermont Auvergne INP, ICCF, F-63000 Clermont-Ferrand, France.ORCID 0000-0002-7256-9154 Béatrice JosselinSorbonne Université, CNRS, Plateforme de Criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Protein Phosphorylation and Human Diseases Unit, Station Biologique, Place Georges Teissier, F-29688 Roscoff, France.
Lionel NautonUniversité Clermont Auvergne, CNRS, Clermont Auvergne INP, ICCF, F-63000 Clermont-Ferrand, France.ORCID 0000-0003-0668-4063 Vincent ThéryUniversité Clermont Auvergne, CNRS, Clermont Auvergne INP, ICCF, F-63000 Clermont-Ferrand, France.
Fabrice AnizonUniversité Clermont Auvergne, CNRS, Clermont Auvergne INP, ICCF, F-63000 Clermont-Ferrand, France.
Sandrine RuchaudSorbonne Université/CNRS UMR8227, Station Biologique, Place Georges Teissier, CS90074, CEDEX, F-29688 Roscoff, France.ORCID 0000-0002-4606-6625 Francis GiraudUniversité Clermont Auvergne, CNRS, Clermont Auvergne INP, ICCF, F-63000 Clermont-Ferrand, France.ORCID 0000-0001-7600-3687 Pascale MoreauUniversité Clermont Auvergne, CNRS, Clermont Auvergne INP, ICCF, F-63000 Clermont-Ferrand, France.ORCID 0000-0001-6527-7586 Centre National de la Recherche Scientifique · FR
Funding
Biogenouest Not applicableITMO Cancer Aviesan Cancer Plan Not ApplicableLigue Nationale Contre le Cancer Not applicableMinistère de l'Enseignement Superieur et de la Recherche Not ApplicableRegional Council of Brittany Not Applicable
6 · The paper itselfAbstract
A new series of pyrazolo[3,4-
Indexed as
IsoquinolinesStructure-Activity RelationshipIsoquinolineskinase inhibitionpyrroloisoquinolines
Identifiers
PMID36080340
PMCPMC9457941
OpenAlexW4293716452
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390